# Relay Therapeutics, Inc. (RLAY)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/RLAY/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 3.00M | $ -73.29M | $ -51.11M | $ 31.57M | $ 642.18M |
| 2025 | $ 15.72M | $ -283.09M | $ -241.51M | $ 32.46M | $ 567.06M |
| 2024 | $ 10.52M | $ -354.96M | $ -263.95M | $ 48.50M | $ 777.79M |
| 2023 | $ 27.62M | $ -369.76M | $ -329.18M | $ 53.47M | $ 752.00M |
| 2022 | $ 1.54M | $ -324.53M | $ -266.49M | $ 57.74M | $ 950.22M |
| 2021 | $ 3.60M | $ -432.52M | $ -92.57M | $ 22.90M | $ 897.81M |
| 2020 | $ 105.30M | $ -66.77M | $ -133.02M | $ 24.42M | $ 763.29M |
| 2019 | $ 0 | $ -97.20M | $ -95.69M | $ 24.83M | $ -180.44M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.05 |
| Liabilities / Eq | 0.09 |
| Current Ratio | 22.13 |

## Other views

- [Metrics](https://sponda.capital/en/RLAY.md)
- [Charts](https://sponda.capital/en/RLAY/charts.md)
- [Compare](https://sponda.capital/en/RLAY/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-13.